Request access for On-Demand

    What happens with my data? We need your contact details in order to grant you access to the on-demand course. In addition, we evaluate the collected data to optimise the quality of future continuing education events. This form does not work with Internet Explorer 11 or an older version. Thank you for your understanding.


    We would like to invite you to our webinar «Management of Patients receiving CAR T Cell Therapy».
    Three national speakers will highlight various aspects of secondary immunodeficiencies after a CAR T cell therapy.
    To attend the webinar of September 13th 2023, please fill in the form.

    For additional information, please contact:

    Dr. Stefanie Buschor
    Senior Medical Science Liaison
    079 657 29 18

    Dr. Christoph Schneider
    Head of Marketing & Sales
    CSL Behring
    079 580 57 49

    Note: The webinar is intended for healthcare professionals only.

    Your opinion counts!

    (1=min, 10=max)

      Quality of the content

      Quality of the presentation

      How likely are you to recommend this event to a colleague?


      17:00 –17:05Welcome and Introduction of SpeakersProf. Dr. Dr. med. Sacha Zeerleder, Luzerner Kantonsspital
      17:05 –17:30CAR T cell therapies:
      how they have revolutionized our treatment landscape
      Prof. Dr. med. Dr. phil. Dominik Schneidawind,
      Universitätsspital Zürich
      17:30–17:55Secondary immune deficiencies after CAR T cell therapyProf. Dr. Dr. med. Sacha Zeerleder, Luzerner Kantonsspital
      17:55–18:15Collaboration between referring physician and treatment centerDr. Jasmine Noetzli, Cabinet Noetzli, Lausanne

      Organized and sponsored by:

      Legal notice

      CSL Behring and Bristol Myers Squibb have engaged POMCANYS Marketing AG to conduct the webinar/webcast. For information on how your personal data is processed click on the following link for CSL Behring and Bristol Myers Squibb.
      Please note that by participating in the webcast it can be concluded that you are entering into a customer relationship with CSL Behring and/or Bristol Myers Squibb.

      CSL Behring AG, Wankdorfstrasse 10, CH-3014 Bern / Bristol Myers Squibb SA, Hinterbergstrasse 16, CH-6312 Steinhausen

      SUI-IMG-0028/ 07.2023